Lactococcus lactis BFE920 activates the innate immune system of olive flounder (Paralichthys olivaceus), resulting in protection against Streptococcus iniae infection and enhancing feed efficiency and weight gain in large-scale field studies

Fish and Shellfish Immunology

Volumn 35, Issue 5, 2013, Pages 1585-1590

  Kim, Daniel ^a   Beck, Bo Ram ^a   Heo, Saet Byeol ^a   Kim, Jungjoon ^a   Kim, Hyun Duk ^a   Lee, Sun Min ^a   Kim, Youngchan ^a   Oh, So Young ^a   Lee, Kyungro ^a   Do, HyungKi ^a   Lee, KwanHee ^a   Holzapfel, Wilhelm H ^a   Song, Seong Kyu ^a  

^a Handong University   (South Korea)

Author keywords

IFN ; IL 12; Lactococcus lactis BFE920; Olive flounder; Probiotics

Indexed keywords

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; LACTOCOCCUS; LACTOCOCCUS GARVIEAE; LACTOCOCCUS LACTIS; PARALICHTHYS OLIVACEUS; PLEURONECTOIDEI; STREPTOCOCCUS; STREPTOCOCCUS INIAE; STREPTOCOCCUS PARAUBERIS;

INTERLEUKIN 12; NITROBLUE TETRAZOLIUM; PRIMER DNA; PROBIOTIC AGENT;

ANIMAL; ANIMAL DISEASE; AQUACULTURE; ARTICLE; DIET SUPPLEMENTATION; DRUG EFFECT; FISH DISEASE; FLOUNDER; GENETICS; IFN-Γ; IMMUNOLOGY; INNATE IMMUNITY; LACTOCOCCUS LACTIS; LACTOCOCCUS LACTIS BFE920; METHODOLOGY; OLIVE FLOUNDER; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS INFECTION; WEIGHT GAIN;

IFN-Γ; IL-12; LACTOCOCCUS LACTIS BFE920; OLIVE FLOUNDER; PROBIOTICS;

ANIMALS; AQUACULTURE; DIETARY SUPPLEMENTS; DNA PRIMERS; FISH DISEASES; FLOUNDER; IMMUNITY, INNATE; LACTOCOCCUS LACTIS; NITROBLUE TETRAZOLIUM; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; WEIGHT GAIN;

EID: 84884974160     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2013.09.008     Document Type: Article

References (24)

1. De Vuyst L., Erick J.V. Nisin, a lantibiotic produced by Lactococcus lactis subsp. lactis: properties, biosynthesis, fermentation and applications. Bacteriocins of lactic acid bacteria 1994, 151-221. Springer, US.
2. Kimoto H., Mizumachi K., Okamoto T., Kurisaki J.I. New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 2004, 48(2):75-82.
3. Drouault S., Juste C., Marteau P., Renault P., Corthier G. Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol 2002, 68(6):3166-3168.
4. Agarwal K.N., Bhasin S.K. Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr 2002, 56:S56-S59.
5. Steidler L., Hans W., Schotte L., Neirynck S., Obermeier F., Falk W., et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000, 289(5483):1352-1355.
6. Steidler L., Rottiers P. Therapeutic drug delivery by genetically modified Lactococcus lactis. Ann NY Acad Sci 2006, 1072(1):176-186.
7. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M., Le Page R.W. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 1997, 15(7):653-657.
8. Mierau I., Kleerebezem M. 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 2005, 68(6):705-717.
9. Anuradha K., Foo H.L., Mariana N.S., Loh T.C., Yusoff K., Hassan M.D., et al. Live recombinant Lactococcus lactis vaccine expressing aerolysin genes D1 and D4 for protection against Aeromonas hydrophila in tilapia (Oreochromis niloticus). JAppl Microbiol 2010, 109(5):1632-1642.
10. Franz C.M.A.P., Du Toit M., Von Holy A., Schillinger U., Holzapfel W.H. Production of nisin-like bacteriocins by Lactococcus lactis strains isolated from vegetables. JBasic Microbiol 1997, 37(3):187-196.
11. Maragkoudakis P.A., Mountzouris K.C., Psyrras D., Cremonese S., Fischer J., Cantor M.D., et al. Functional properties of novel protective lactic acid bacteria and application in raw chicken meat against Listeria monocytogenes and Salmonella enteritidis. Int J Food Microbiol 2009, 130(3):219-226.
12. Pier G.B., Madin S.H. Streptococcus iniae sp. nov., a beta-hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Int J Syst Bacteriol 1976, 26(4):545-553.
13. Kitao T., Aoki T., Sakoh R. Epizootic caused by beta-hemolytic Streptococcus species in cultured freshwater fish. Fish Pathol 1981, 15:301-307.
14. Plumb J.A., Schachte J.H., Gaines J.L., Peltier W., Carroll B. Streptococcus sp. from marine fishes along the Alabama and northwest Florida coast of the Gulf of Mexico. Trans Am Fish Soc 1974, 103(2):358-361.
15. Moon J.S., Kim J.Y., Job S.J., Kim M.J., Son S.W., Jang H. Influence on efficacy of β-hemolytic Streptococcus iniae vaccine by mixed infections with Edwardsiella tarda and Neoheterobothrium hirame in cultured olive flounder, Paralichthys olivaceus. JVet Clini 2009, 26(3):226-230.
16. Lahav D., Eyngor M., Hurvitz A., Ghittino C., Lublin A., Eldar A. Streptococcus iniae type II infections in rainbow trout Oncorhynchus mykiss. Dis Aquat Org 2004, 62(1-2):177-180.
17. Agnew W., Barnes A.C. Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol 2007, 122:1-15.
18. Cabello F.C. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol 2006, 8(7):1137-1144.
19. Alderman D.J., Hastings T.S. Antibiotic use in aquaculture: development of antibiotic resistance-potential for consumer health risks. Int J Food Sci Technol 1998, 33(2):139-155.
20. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., et al. Demonstration of safety of probiotics-a review. Int J Food Microbiol 1998, 44(1):93-106.
21. Gatesoupe F.J. The use of probiotics in aquaculture. Aquaculture 1999, 180(1):147-165.
22. Schoenborn J.R., Christopher B.W. Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol 2007, 96:41-101.
23. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanisms and functions. Immunity 2010, 32(5):593-604.
24. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., et al. Aphase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006, 4(6):754-759.